Linamar signs manufacturing agreement with Synaptive Medical

Linamar Corporation entered into an exclusive Strategic Manufacturing Agreement with Synaptive Medical Inc. to manufacture Synaptive's Modus V and Evry products, and made a $5 million equity investment in Synaptive. The announcement was made on December 10, 2019.

“The deal leverages Linamar's manufacturing expertise and infrastructure, design for manufacturing capabilities, and supply chain management expertise to allow for rapid commercialization of Synaptive's products.”newswire.ca

• 2 sources
• newswire.caLinamar Announces Strategic Manufacturing Agreement and Concurrent Investment in Synaptive Medical, Inc. to Diversify Into Rapidly Growing Medical Biotech MarketLinamar CorporationDec 10, 2019
• design-engineering.comLinamar To Diversify Into Medical Robotics Market - Design EngineeringMike McLeodDec 16, 2019

Summarized from public sources; check the original articles before acting on it.